Stocks
Funds
Screener
Sectors
Watchlists
ZTS

ZTS - Zoetis Inc Stock Price, Fair Value and News

$121.89-3.07 (-2.46%)
Market Closed

55/100

ZTS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

55/100

ZTS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$121.82

Target 3M

$123.43

Target 6M

$122.93

ZTS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ZTS Price Action

Last 7 days

-2.5%

Last 30 days

-3.2%

Last 90 days

-15.4%

Trailing 12 Months

-28.5%

ZTS RSI Chart

ZTS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ZTS Valuation

Market Cap

53.7B

Price/Earnings (Trailing)

20.26

Price/Sales (Trailing)

5.72

EV/EBITDA

14.54

Price/Free Cashflow

23.98

ZTS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$121.82

Target 3M

$123.43

Target 6M

$122.93

ZTS Fundamentals

ZTS Revenue

Revenue (TTM)

9.4B

Rev. Growth (Yr)

0.5%

Rev. Growth (Qtr)

-2.44%

ZTS Earnings

Earnings (TTM)

2.7B

Earnings Growth (Yr)

5.72%

Earnings Growth (Qtr)

0.42%

ZTS Profitability

EBT Margin

35.45%

Return on Equity

49.11%

Return on Assets

17.49%

Free Cashflow Yield

4.17%

ZTS Investor Care

Dividend Yield

1.59%

Dividend/Share (TTM)

1.93

Buy Backs (1Y)

2.32%

Diluted EPS (TTM)

5.94

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20259.3B9.4B9.4B0
20248.7B8.9B9.2B9.3B
20238.1B8.2B8.4B8.5B
20227.9B8.0B8.0B8.1B
20217.0B7.4B7.6B7.8B
20206.3B6.3B6.5B6.7B
20195.9B6.0B6.2B6.3B
20185.4B5.6B5.7B5.8B
20175.0B5.0B5.1B5.3B
20164.8B4.9B4.9B4.9B
20154.8B4.8B4.8B4.8B
20144.6B4.6B4.7B4.8B
20134.4B4.4B4.5B4.6B
20124.3B4.3B4.3B4.3B
20113.7B3.9B4.1B4.2B
20100003.6B
ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
 CEO
 WEBSITEzoetis.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES13800

Zoetis Inc Frequently Asked Questions


ZTS is the stock ticker symbol of Zoetis Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Zoetis Inc is 53.72 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check ZTS's fair value in chart for subscribers.

The fair value guage provides a quick view whether ZTS is over valued or under valued. Whether Zoetis Inc is cheap or expensive depends on the assumptions which impact Zoetis Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZTS.

As of Wed Jan 28 2026, ZTS's PE ratio (Price to Earnings) is 20.26 and Price to Sales (PS) ratio is 5.72. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZTS PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Zoetis Inc has provided 0.11 (multiply by 100 for percentage) rate of return.